Human growth hormone (hGH)
Human growth hormone (hGH) has been shown to be heterogenous in plasma with respect to molecular size (Goodman et al., 1972; Gorden et al., 1973; Lewis et al., 1980) . Further the major component, "little" or 22K hGH, has been shown to have a high receptor-reactive to immunoreactive potency in plasma from acromegalic subjects than normal subjects (Gorden et al., 1976) . hGH immunoreactivity (vertical axis) is plotted as a function of the elution volume of the column (horizontal axis). In addition, higher molecular weight components were found consisting of an approximately 45K protein, "big" hGH, and higher molecular component, "pre-big" hGH. The gel filtration pattern of immunoreactive hGH in pituitary extracts from seven patients with acromegaly and nine normal subjects were investigated (Table 1 ). The percentage of "little" hGH in total immunoreactive hGH for acromegaly was slightly higher but not significantly than that for normal. There were no significant differences in the proportions of both "big" and "pre -big" hGH between acromegaly and normal.
RRA to RIA ratios of hGH in "little", "big", and "pre-big" hGH We next studied the RRA to RIA ratios of hGH in "little", "big", and "pre-big" hGH components in the pituitary extracts. from patients with acromegaly were higher than those from normal, and that the RRA to RIA ratios of hGH for the higher molecular weight components of hGH ("pre-big" and "big" hGH) in pituitary extracts from both acromegaly and normal were lower than those for "little" hGH. The finding that the hGH produced in acromegaly had higher receptor binding activity than that for normal is similar to that observed in plasma hGH by Gorden et al. (1976) . By contrast, Rosenfeld and Hintz (1980) and Gavin et al. (1982) did not find any differences in receptor binding activity of plasma hGH between acromegaly and normal.
These different results might be explained in part by the different anti-hGH antibody and hGH standard used in the assays. In our study the mean RRA to RIA ratios of hGH in acromegaly were statistically higher than those of normals, but in some acromegalic patients these ratios were not different from normal. It is to be noted, however, that one patient with active acromegaly whose plasma hGH found by RIA was only 5ng/ml, had the highest RRA to RIA ratio of hGH in the pituitary extract. In this case it is reasonable to suppose that the higher receptor-reactive hGH is responsible for these clinical manifestations.
Recent recombinant DNA technology has shown that the human genome contains five hGH related genes (Barsh et al., 1983) . One of these, designated hGH 2 gene or hGH-V gene, encodes a variant hGH peptide which differs by 13 amino acids from authentic hGH (hGH 1 or hGH-N) (Seeburg 1982) . When the hGH 2 gene is expressed in monkey kidney cells, this peptide has a higher RRA to RIA ratio of hGH than hGH 1 (Pavlakis et al., 1981; Hizuka et al., 1982) . Whether this variant hGH is produced in the pituitary is not known, but mixtures of variant hGH and authentic hGH could explain our findings in this study.
Briefly, this study provides a direct demonstration that pituitary hGH from some acromegalic patients has greater receptorreactivity than immunoreactivity in comparison with hGH from normal pituitary.
